Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease.
暂无分享,去创建一个
[1] A. Jemal,et al. Trends in the leading causes of death in the United States, 1970-2002. , 2005, JAMA.
[2] K. Rabe,et al. From COPD to chronic systemic inflammatory syndrome? , 2007, The Lancet.
[3] M. Decramer,et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey , 2002, European Respiratory Journal.
[4] F. Crea,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[5] D. Forman,et al. Delays in managing lung cancer. , 2004, Thorax.
[6] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[7] K. R. Chapman,et al. Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[8] W. Kannel,et al. Pulmonary Function: Relation to Aging, Cigarette Habit, and Mortality , 1975 .
[9] Alan D. Lopez,et al. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.
[10] W. Bailey,et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .
[11] M. Spitz,et al. The Biology of Tobacco and Nicotine: Bench to Bedside , 2005, Cancer Epidemiology Biomarkers & Prevention.
[12] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[13] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[14] A. Agustí. Thomas a. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. , 2006, Proceedings of the American Thoracic Society.
[15] J. Barberà,et al. [Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]. , 2008, Archivos de bronconeumologia.
[16] P. Sterk. Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1 , 2004, European Respiratory Journal.
[17] C. Block,et al. Mechanisms linking obesity with cardiovascular disease , 2006, Nature.
[18] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[19] G. Davey Smith,et al. The natural history of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[20] Taghreed Adam,et al. The burden and costs of chronic diseases in low-income and middle-income countries , 2007, The Lancet.
[21] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[22] M. Ferrer,et al. Chronic Obstructive Pulmonary Disease Stage and Health-Related Quality of Life , 1997, Annals of Internal Medicine.
[23] Sherman Cb. Health effects of cigarette smoking. , 1991 .
[24] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[25] K. Chapman. Chronic obstructive pulmonary disease: are women more susceptible than men? , 2004, Clinics in chest medicine.
[26] A Senthilselvan,et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.
[27] C. D. Mathers,et al. Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.
[28] John Connett,et al. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.
[29] A. Buist,et al. The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.
[30] D. Postma,et al. Relation between duration of smoking cessation and bronchial inflammation in COPD , 2005, Thorax.
[31] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[32] R. Taylor,et al. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE) , 2002, International Journal of Technology Assessment in Health Care.
[33] X. Busquets,et al. Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[34] E. Wouters,et al. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. , 2000, Clinics in chest medicine.
[35] K. Rabe,et al. Complex chronic comorbidities of COPD , 2008, European Respiratory Journal.
[36] R. Stockley,et al. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype? , 2006, Respiratory research.
[37] Fernando Costa,et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.
[38] E. Wouters,et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.
[39] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[40] N. Anthonisen,et al. Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.
[41] D. Mannino,et al. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. , 2003, Archives of internal medicine.
[42] Karel G M Moons,et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study , 2005, BMJ : British Medical Journal.
[43] S. Suissa,et al. Cardiovascular morbidity and mortality in COPD. , 2005, Chest.
[44] J. Wedzicha,et al. Causes of death in patients with COPD and chronic respiratory failure. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[45] Judith K Jones,et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. , 2006, Annals of epidemiology.
[46] F. Rutten,et al. Heart failure and chronic obstructive pulmonary disease: An ignored combination? , 2006, European journal of heart failure.
[47] A. Agustí,et al. Chronic obstructive pulmonary disease : A systemic disease , 2006 .
[48] E. Wouters,et al. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[49] François G Schellevis,et al. Comorbidity and guidelines: conflicting interests , 2006, The Lancet.
[50] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[51] D. Jacobs,et al. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. , 1999, Archives of internal medicine.